Finance / PPHM (Peregrine Pharmaceuticals Inc.)

Jessme, I am surprised you want someone to look up the stock option status for you, since you typically have addressed such routine matters yourself. However, you are insistent, so as a favor, I looked up some of the statistics in PPHM releases and suggest you review Pages 13 and 20 of the Annual Share holder Meeting Proxy. There is a listing of the current holdings, options, including expiration...

From BioInvestor: http://www.biohealthinvestor.com/2009/11/hope-for- new-brain-cancer-treatment-pphm-pphmd.html Hope for New Brain Cancer Treatment (PPHM, PPHMD) November 10, 2009 · Filed Under Cancer, R&D Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) has been in the news quite a bit of late, which is odd for a company its size. Recently it announced its second broad U.S. patent for anti-viral ...

PR 11-3-09: PPHM Regains Full Nasdaq Compliance Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements PRNewsWire.com: http://tinyurl.com/yzfklbu TUSTIN, Nov. 3 2009: Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that on November 3, 2009, the Company received notice from the NASDAQ Market Listing Qualifications Department ...

PR 11-3-09: PPHM Regains Full Nasdaq Compliance Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements PRNewsWire.com: http://tinyurl.com/yzfklbu TUSTIN, Nov. 3 2009: Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that on November 3, 2009, the Company received notice from the NASDAQ Market Listing Qualifications Department stating that it has...

Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements PRNewsWire.com: http://tinyurl.com/yzfklbu TUSTIN, Nov. 3 2009: Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that on November 3, 2009, the Company received notice from the NASDAQ Market Listing Qualifications Department stating that it has regained compliance with the ...

PPHM: Shares of Peregrine traded with some strength on Monday after the company opened trading after having have conducted a 1:5 reverse split. The company also took the opportunity on Monday morning to announce that former Genentech Senior Executive Dr. Robert Garnick has joined Peregrine as the Head of Regulatory Affairs. http://seekingalpha.com/article/167557-peregrine-c ontinuing-to-accumulate...

This board is a duplicate and will be deleted Peregrine Pharmaceuticals 1:5 Reverse Stock Split Takes Effect TUSTIN, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) today announced that the previously announced 1-for-5 reverse stock split of the Company's common stock will become effective at 9:30 a.m. EDT today. Peregrine's shares will continue to trade on...

KT RE "Can you explain to the PPHM investment community how shares get "lost" when a company is implementing a reverse split?" Not sure how you can debate simple math. shareholders did lose 80% of their shares - that's a fact. It's the nature of a 1 for 5 reverse split! Perhaps you were talking about total authorized shares? If so, you are right, they remain unchanged, which of course creates a ...

Peregrine Pharmaceuticals 1:5 Reverse Stock Split Takes Effect TUSTIN, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) today announced that the previously announced 1-for-5 reverse stock split of the Company's common stock will become effective at 9:30 a.m. EDT today. Peregrine's shares will continue to trade on the NASDAQ Capital Market under the symbol "...

Peregrine Pharmaceuticals 1:5 Reverse Stock Split Takes Effect TUSTIN, Calif., Oct 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the previously announced 1-for-5 reverse stock split of the Company's common stock will become effective at 9:30 a.m. EDT today. Peregrine's shares will continue to trade on the NASDAQ ...